Cancer Pain Management: Comprehensive Assessment and Nonopioid Analgesics, Part 1
Rita J. Wickham, PhD, RN, AOCN®
Rush University College of Nursing (Adjunct Faculty), Chicago, Illinois
Author’s disclosures of potential conflicts of interest are found at the end of this article.
Rita Wickham, PhD, RN, AOCN®, 8039 Garth Point Lane, Rapid River, MI 49878. E-mail: firstname.lastname@example.org
J Adv Pract Oncol 2017;8:475–490 |
© 2017 Harborside Press®
Pain is still undertreated and thus a significant problem for at least half of all cancer patients. Inadequately managed cancer pain may cause significant morbidity and even affect mortality, as well as patient quality of life. One enduring problem is suboptimal pain education in basic and advanced educational programs, and many myths and knowledge gaps persist. This article focuses on identifying and dispelling myths, thorough baseline and ongoing pain assessment, pain documentation, and interprofessional collaboration. It includes a comprehensive review of appropriate use of nonopioid analgesics—nonsteroidal anti-inflammatory agents and acetaminophen, and so-called adjuvant analgesics, such as antidepressants, anticonvulsants, and other drugs.
For access to the full length article, please sign in